Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,069,500 | 4,328,800 | -2,071,900 | 2,953,000 | 2,662,700 |
| Depreciation Amortization | 1,328,200 | 1,297,800 | 1,122,600 | 1,047,900 | 801,800 |
| Income taxes - deferred | 559,700 | 189,900 | 442,600 | 60,700 | 346,800 |
| Accounts receivable | -319,100 | -492,900 | 799,100 | -842,700 | 243,900 |
| Accounts payable and accrued liabilities | -363,900 | -200,100 | -1,608,300 | 990,400 | -936,000 |
| Other Working Capital | -185,500 | -956,900 | 924,200 | -53,800 | -795,300 |
| Other Operating Activity | 767,900 | 168,900 | 7,687,300 | 999,000 | 1,652,000 |
| Operating Cash Flow | $6,856,800 | $4,335,500 | $7,295,600 | $5,154,500 | $3,975,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -686,500 | 399,100 | 957,600 | -376,900 | 1,247,500 |
| PPE Investments | -669,700 | -747,300 | -921,500 | -1,050,100 | -1,012,600 |
| Net Acquisitions | -609,400 | N/A | -6,083,000 | -2,673,200 | N/A |
| Purchase Of Investment | -1,067,200 | -432,300 | -2,412,400 | -750,700 | -1,313,200 |
| Sale Of Investment | 584,700 | 1,107,800 | 1,597,300 | 800,100 | 1,507,700 |
| Purchase Sale Intangibles | -442,400 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -711,700 | -184,500 | -406,800 | -277,300 | 179,000 |
| Investing Cash Flow | $-3,159,800 | $142,800 | $-7,268,800 | $-4,328,100 | $608,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 125,100 | -5,824,200 | 5,060,500 | -468,500 | -8,400 |
| Debt Issued | N/A | 2,400,000 | 100 | 2,512,600 | N/A |
| Debt Repayment | -1,100 | N/A | -649,800 | -1,059,500 | -2,781,500 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 59,600 |
| Common Stock Repurchased | 0 | N/A | N/A | N/A | -122,100 |
| Dividend Paid | -2,165,300 | -2,152,100 | -2,056,700 | -1,853,600 | -1,736,300 |
| Other Financing Activity | 19,400 | 42,600 | -8,100 | 24,100 | 9,900 |
| Financing Cash Flow | $-2,021,900 | $-5,533,700 | $2,346,000 | $-844,900 | $-4,578,800 |
| Exchange Rate Effect | -144,800 | 21,600 | -96,600 | 129,700 | 97,100 |
| Beginning Cash Position | 4,462,900 | 5,496,700 | 3,220,500 | 3,109,300 | 3,006,700 |
| End Cash Position | 5,993,200 | 4,462,900 | 5,496,700 | 3,220,500 | 3,109,300 |
| Net Cash Flow | $1,530,300 | $-1,033,800 | $2,276,200 | $111,200 | $102,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,856,800 | 4,335,500 | 7,295,600 | 5,154,500 | 3,975,900 |
| Capital Expenditure | -694,300 | -765,000 | -947,200 | -1,082,400 | -1,077,800 |
| Free Cash Flow | 6,162,500 | 3,570,500 | 6,348,400 | 4,072,100 | 2,898,100 |